Two Day Seminar: Data Integrity - FDA/EU Requirements and Implementation (Opfikon, Switzerland - April 6th-7th, 2017) - Research and Markets

DUBLIN, Mar. 6, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Data Integrity: FDA/EU Requirements and Implementation: 2-Day Workshop by Dr. Huber" conference to their offering.

There is no doubt that data integrity is the current and future inspection focus of all regulatory heath care agencies. More than 50% inspection reports such as 483's and Warning Letters quote data integrity as deviations from GxP regulations.

This new 2-day course provides the regulatory background and guides attendees through the complete record lifecycle from data entry or acquisition through evaluation, reporting, archiving and retrieval. It also helps to fully understand not only the text but also the meaning of related regulations such as FDA's Part 11 and the EU/PICS Annex 11.

The 2-day course not only ensures a full understanding of the regulations and guidelines for raw data and other records but also provides templates and examples to develop inspection ready documentation. Interactive exercises will be dispersed into and between the presentations. About 50% of the total time will be dedicated to practical sessions. Here attendees work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned in the course.

Learning Objectives:

- Understand what data integrity is and why it is so important for public health
- Learn why there are so many data integrity issues
- Learn about the FDA/EU/PICS/MHRA/WHO requirements for data integrity
- Understand how to define and archive raw data from hybrid systems: electronic vs. paper
- Be able to specify and validate Part 11 compliant software functionality
- Learn how to ensure and document integrity of raw data and other records according to Part 11 and Annex 11
- Understand FDA's New and ongoing Part 11 inspection and enforcement practices
- Learn how to develop and implement corrective and preventive action plans in response to inspection reports
- Learn how to avoid and/or respond to FDA inspectional observations and warning letters
- Learn how to prevent and detect data integrity issues

Who Should Attend:

- QA managers and personnel
- Laboratory managers and supervisors
- Production managers and supervisors
- Analysts
- IT/IS managers and system administrators
- Software developers
- Regulatory affairs
- Training departments
- Documentation departments
- Consultants

Agenda:

Day 01 (8:30 AM - 4:30 PM)

08.30 AM - 09.00 AM: Registration

09.00 AM: Session Start

Day 1 - Lectures and Workshop Exercises

Module 1: Definitions, requirements and approaches for data integrity

Module 2: Introduction to FDA 21 CFR Part 11 and EU/PICS Annex 11

Module 3: Cost effective Validation of software and computer systems

Module 4: Aligning data integrity with the company's quality system and Code of Conduct

Day 02 (8:30 AM - 4:30 PM)

Day 2 - Lectures and Workshop Exercises

Module 5: Definition and Handling of Raw Data

Module 6: Good documentation practices to ensure data integrity

Module 7: Strategies to detect and avoid integrity issues

Module 8: Data Integrity Auditing: Internal audits and FDA inspections

For more information about this conference visit http://www.researchandmarkets.com/research/83kzvh/data_integrity

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets